Smart Immune to Present ReSet-02 Phase I Preliminary Data and the Determination of the Recommended Dose at ASH 2024
November 5, 2024
January 10, 2022
40th annual J.P. Morgan Healthcare conference - Smart Immune will be in San Francisco
40th annual J.P Morgan Healthcare conference: following our latest announcement on the launch of the T-cell progenitor-based platform, we are looking forward to meeting there and share our latest progress.
